Monthly Archives: June 2012

Pradaxa and its Risks

A prescription anti-clotting drug known as Pradaxa by Behringer Ingelheim had first been approved in the European Union for sales and marketing on March of 2008. In the United States, Pradaxa was first approved for sale in October 2010. More than 1,000,000 prescriptions of Pradaxa have been prescribed for over 300,000 patients in U.S. since…
Read More